These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12724513)

  • 1. Seizures associated with venlafaxine, methylphenidate, and zolpidem.
    Tavakoli SA; Gleason OC
    Psychosomatics; 2003; 44(3):262-4. PubMed ID: 12724513
    [No Abstract]   [Full Text] [Related]  

  • 2. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
    Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
    Bader GM; Hawley JM; Short DD
    J Clin Psychopharmacol; 1998 Jun; 18(3):255-6. PubMed ID: 9617988
    [No Abstract]   [Full Text] [Related]  

  • 5. Bupropion-methylphenidate combination and grand mal seizures.
    Ickowicz A
    Can J Psychiatry; 2002 Oct; 47(8):790-1. PubMed ID: 12420664
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.
    Kito S; Koga Y
    Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 8. An open clinical trial of venlafaxine treatment of fibromyalgia.
    Dwight MM; Arnold LM; O'Brien H; Metzger R; Morris-Park E; Keck PE
    Psychosomatics; 1998; 39(1):14-7. PubMed ID: 9538670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label trial of venlafaxine in adults with attention deficit disorder.
    Adler LA; Resnick S; Kunz M; Devinsky O
    Psychopharmacol Bull; 1995; 31(4):785-8. PubMed ID: 8851654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study.
    Mattos P; Louzã MR; Palmini AL; de Oliveira IR; Rocha FL
    J Atten Disord; 2013 Jul; 17(5):444-8. PubMed ID: 22334621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 13. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
    Hedges D; Reimherr FW; Rogers A; Strong R; Wender PH
    Psychopharmacol Bull; 1995; 31(4):779-83. PubMed ID: 8851653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive use of methylphenidate in the treatment of psychotic unipolar depression.
    Huang CC; Shiah IS; Chen HK; Mao WC; Yeh YW
    Clin Neuropharmacol; 2008; 31(4):245-7. PubMed ID: 18670250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine drug-drug interactions in clinical practice.
    Benazzi F
    J Psychiatry Neurosci; 1998 May; 23(3):181-2. PubMed ID: 9595894
    [No Abstract]   [Full Text] [Related]  

  • 18. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC; Cox DJ
    J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
    [No Abstract]   [Full Text] [Related]  

  • 19. Myoclonus during prolonged treatment with sertraline in an adolescent patient.
    Ghaziuddin N; Iqbal A; Khetarpal S
    J Child Adolesc Psychopharmacol; 2001; 11(2):199-202. PubMed ID: 11436961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
    van der Feltz-Cornelis CM; Aldenkamp AP
    Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.